Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
+21.72%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$10.9B
AUM Growth
+$1.89B
(+21%)
Cap. Flow
+$185M
Cap. Flow
% of AUM
1.7%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
2,159
New
88
Increased
945
Reduced
633
Closed
96
Top Buys
| 1 |
Apple
AAPL
|
$16.9M |
| 2 |
Meta Platforms (Facebook)
META
|
$15M |
| 3 |
Amazon
AMZN
|
$12.2M |
| 4 |
AbbVie
ABBV
|
$12M |
| 5 |
American Tower
AMT
|
$9.94M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$18.9M |
| 2 |
RTN
Raytheon Company
RTN
|
$12.4M |
| 3 |
Chubb
CB
|
$6.08M |
| 4 |
Microsoft
MSFT
|
$5.97M |
| 5 |
Procter & Gamble
PG
|
$5.32M |
Sector Composition
| 1 | Technology | 22.29% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRFT
1776
DELISTED
Perficient Inc
PRFT
| $20K | ﹤0.01% |
550
+50
| +10% | +$1.82K |
|
|
DRNA
1777
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $20K | ﹤0.01% |
775
+225
| +41% | +$5.81K |
|
|
AHT
1778
Ashford Hospitality Trust
AHT
$37.7M
| $19K | ﹤0.01% |
26
| – | – |
|
1779
Alarm.com
ALRM
$2.84B
| $19K | ﹤0.01% |
300
| – | – |
|
1780
ATI
ATI
$10.7B
| $19K | ﹤0.01% |
1,855
+625
| +51% | +$6.4K |
|
1781
Cabot Corp
CBT
$4.31B
| $19K | ﹤0.01% |
500
| – | – |
|
1782
Cleveland-Cliffs
CLF
$5.63B
| $19K | ﹤0.01% |
3,510
+614
| +21% | +$3.32K |
|
1783
Fate Therapeutics
FATE
$116M
| $19K | ﹤0.01% |
555
+30
| +6% | +$1.03K |
|
1784
Ovintiv
OVV
$10.6B
| $19K | ﹤0.01% |
+2,020
| New | +$19K |
|
1785
Ponce Financial Group
PDLB
$339M
| $19K | ﹤0.01% |
+2,651
| New | +$19K |
|
1786
Rambus
RMBS
$8.05B
| $19K | ﹤0.01% |
1,250
-270
| -18% | -$4.1K |
|
1787
Vir Biotechnology
VIR
$732M
| $19K | ﹤0.01% |
460
+360
| +360% | +$14.9K |
|
|
BEAT
1788
DELISTED
BioTelemetry, Inc.
BEAT
| $19K | ﹤0.01% |
415
+190
| +84% | +$8.7K |
|
1789
Amkor Technology
AMKR
$6.09B
| $18K | ﹤0.01% |
1,425
+505
| +55% | +$6.38K |
|
1790
Apellis Pharmaceuticals
APLS
$3.55B
| $18K | ﹤0.01% |
550
| – | – |
|
1791
Banc of California
BANC
$2.65B
| $18K | ﹤0.01% |
1,620
| – | – |
|
1792
BridgeBio Pharma
BBIO
$10.2B
| $18K | ﹤0.01% |
550
| – | – |
|
1793
Costamare
CMRE
$1.45B
| $18K | ﹤0.01% |
3,150
| – | – |
|
1794
Diamond Hill
DHIL
$388M
| $18K | ﹤0.01% |
155
-25
| -14% | -$2.9K |
|
1795
Denali Therapeutics
DNLI
$2.26B
| $18K | ﹤0.01% |
760
+300
| +65% | +$7.11K |
|
1796
Kodiak Sciences
KOD
$556M
| $18K | ﹤0.01% |
335
+95
| +40% | +$5.1K |
|
1797
MACOM Technology Solutions
MTSI
$9.67B
| $18K | ﹤0.01% |
535
+45
| +9% | +$1.51K |
|
1798
Mueller Water Products
MWA
$4.19B
| $18K | ﹤0.01% |
1,860
+290
| +18% | +$2.81K |
|
1799
National Bankshares
NKSH
$198M
| $18K | ﹤0.01% |
615
+145
| +31% | +$4.24K |
|
1800
Old Second Bancorp
OSBC
$970M
| $18K | ﹤0.01% |
2,275
+145
| +7% | +$1.15K |
|